SenesTech, Inc. - SNES STOCK NEWS

SenesTech (NASDAQ: SNES) has announced a significant deployment of its EPA registered contraceptive, ContraPest, at the Los Angeles Zoo. The initial rollout involves 17 bait stations, expanding to over 250 as confidence grows. ContraPest has shown up to 90% efficacy improvement over traditional pest control methods, addressing issues common to zoo environments. This deployment is part of a market expansion opportunity, as SenesTech reports that the zoo and sanctuary vertical has grown over 300% in the past year, now serving nearly 70 customers.

SenesTech (NASDAQ: SNES) closed a public offering of 1,428,572 shares at $3.50 each, generating approximately $5 million in gross proceeds. The offering included Series A and Series B warrants, both with an exercise price of $3.165, expiring five years and thirteen months respectively. Proceeds will be utilized for general corporate purposes. Additionally, existing warrants were amended to reduce their exercise price to $3.165 per share. The offering was facilitated by H.C. Wainwright & Co.

SenesTech (NASDAQ: SNES) announced a public offering of up to 1,428,572 shares at $3.50 each, intending to raise approximately $5 million before expenses. This offering includes Series A and Series B warrants at an exercise price of $3.165. The public offering is scheduled to close around November 18, 2022, with proceeds aimed for general corporate purposes. Additionally, existing warrants will be amended to align with the new exercise price. H.C. Wainwright & Co. is the exclusive placement agent.

SenesTech (NASDAQ: SNES) announced a 1-for-20 reverse stock split effective November 15, 2022. This action will reduce the total shares from approximately 12.2 million to about 610,648. The stock will trade on a split-adjusted basis starting November 16, 2022. The reverse split was approved by shareholders on October 12, 2022, to potentially increase the stock price and maintain compliance with Nasdaq listing requirements. This measure aims to improve shareholder value and align the company's stock with market expectations.

SenesTech, Inc. (NASDAQ: SNES) reported significant growth in its third quarter 2022 results, with product sales increasing by 57% year-over-year. Total revenue reached approximately $250,000, a 36% rise from Q3 2021. The company's e-commerce platform grew by 173%, contributing over 50% of sales. Despite these gains, the net loss widened to $(2.6) million from $(2.3) million in Q3 2021. New CEO Joel Fruendt emphasized sustainability in pest management. Challenges included delays in product deployment due to avian influenza affecting poultry operations.

SenesTech, Inc. (NASDAQ: SNES) has appointed Joel Fruendt as its new Chief Executive Officer, succeeding Ken Siegel, who will retire at the year's end while remaining as an Executive Director during the transition. Fruendt brings over 15 years of experience in the pest control industry, previously holding senior roles at Clarke Environmental Inc. and a global manufacturing firm. His appointment aligns with SenesTech's strategy to enhance the commercialization of ContraPest, its EPA-registered rodent fertility control product, aiming for sustainable pest management solutions.

SenesTech, Inc. (NASDAQ: SNES) is set to release its financial results for the third quarter of 2022, ending September 30, 2022, on November 14, 2022, before market open. A conference call will follow at 11:00 am ET to discuss the findings. The company focuses on innovative pest control through its patented product, ContraPest, designed to manage rat populations sustainably. Stakeholders can access the call via phone or live webcast and will have a replay option for later review.

SenesTech, Inc. (NASDAQ: SNES) will participate in the Lytham Partners Fall 2022 Investor Conference on September 28-29, 2022. The company specializes in managing animal pest populations through fertility control, particularly focusing on rat populations. A webcast of their presentation will be available at 9:00am ET on September 28, and it will be archived for later replay. Additionally, management will hold virtual one-on-one meetings during the conference. SenesTech is known for ContraPest, the first U.S. EPA-registered rodent contraceptive.

SenesTech, Inc. (NASDAQ: SNES) has declared a dividend of one one-thousandth of a share of newly designated Series C Preferred Stock for each outstanding share of common stock held as of September 5, 2022. This Series C Preferred Stock will have significant voting rights concerning amendments to the company's charter. Unvoted shares will be redeemed for $0.001 in cash. The company plans to file a report with the SEC and a special meeting notice regarding a potential reverse stock split. SenesTech is known for its eco-friendly rodent fertility control product, ContraPest.